advertisement

Accelerate your drug discovery pipeline with AI-powered molecular modelling

BioSim Pro · Trusted by 400+ research institutions globally · 30-day free trial

CRISPR base editing corrects sickle cell mutation in 97% of patient cells · Phase III mRNA cancer vaccine shows 44% reduction in recurrence · Gut microbiome linked to treatment-resistant depression — Nature study · Novo Nordisk acquires rare disease biotech for $3.2B · FDA grants breakthrough designation to novel Alzheimer's antibody ·
CRISPR base editing corrects sickle cell mutation in 97% of patient cells · Phase III mRNA cancer vaccine shows 44% reduction in recurrence · Gut microbiome linked to treatment-resistant depression — Nature study · Novo Nordisk acquires rare disease biotech for $3.2B · FDA grants breakthrough designation to novel Alzheimer's antibody ·

FREE NEWSLETTER · EST. 2026

Welcome to the
Biomed Today  Community

Join thousands of researchers, clinicians and science professionals who rely on Biomed Today for research highlights, biotech news and expert opinion — delivered free to your inbox.
 

Subscribe to Biomed Today

Complete the form below — takes less than 60 seconds

Personal Details

Join Our Community

Biomed Today is read by researchers, clinicians, and science professionals across the world.

Subscribers worldwide
0 K+
Open rate among researchers
0 %
Newsletter editions available
0

Biomed Today gives me a concise, reliable overview of the research that matters most — without the noise.

Dr. A. Rahman

Postdoctoral Researcher · UCL

Advertisement

MolDock Suite

Molecular docking & MD simulation for academic & pharma teams.